50 Folgen

Pharm Exec podcast goes beyond the pages of Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.

Pharm Exec Podcast Pharmaceutical Executive Magazine

    • Wirtschaft

Pharm Exec podcast goes beyond the pages of Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.

    Episode 50: Pharma Pricing Climate in Washington

    Episode 50: Pharma Pricing Climate in Washington

    Mike Strazzella, head of federal government relations for Buchanan Ingersoll & Rooney, talks about pricing issues in the pharmaceutical industry, the challenges he encounters, and what he believes needs to change in the industry going forward.

    • 19 Min.
    Episode 49: Navigate Emerging Markets with Data Science

    Episode 49: Navigate Emerging Markets with Data Science

    Pharm Exec speaks with Nigel Breakwell and Ben Randal, co-founders of Dot I/O Health. Nigel and Ben talk about how they’re using data science in the health and life sciences industries to help clients navigate emerging markets.

    • 23 Min.
    Episode 48: 2020 Industry Outlook

    Episode 48: 2020 Industry Outlook

    Pharm Exec editors discuss the themes chosen for the January issue focusing on industry trends for the coming year.

    • 21 Min.
    Episode 47: Identifying Adherence Issues

    Episode 47: Identifying Adherence Issues

    Heather Monte, Director of Operations for DirectRx, talks about the specialty pharma’s new Patient Scorecard, which aims to identify and improve adherence by reporting patients’ prescription patterns to doctors.

    • 9 Min.
    Episode 46: Persistence and Planning Pays Off

    Episode 46: Persistence and Planning Pays Off

    Julia Owens, co-founder and CEO of Millendo Therapeutics talks about how to keep a company on the path to success, even when there are bumps in the road. She discusses the value of focusing on strengths and how that is currently working for Millendo in the endocrine space.

    • 14 Min.
    Episode 45: Getting Drug Approval Through FDA LPAD

    Episode 45: Getting Drug Approval Through FDA LPAD

    William Lewis, chairman and CEO of Insmed talks about the approval of the company’s drug Arikayce through the FDA’s Limited Population Pathway for Antibacterial and Antifungal Drugs, some ideas that he spoke about on the recent NORD panel about innovative and ethical partnerships, and Insmed’s pipeline and progress.

    • 27 Min.

Top‑Podcasts in Wirtschaft

Zuhörer haben auch Folgendes abonniert: